Tenet Healthcare CORP

Tenet Healthcare Corporation announced robust second quarter 2026 financial results, exceeding expectations and leading to an upward revision of its full-year 2026 financial guidance.

Tenet Healthcare Corporation shareholders re-elected all director nominees and approved executive compensation at the 2026 Annual Meeting.

Tenet Healthcare Corporation announced robust first quarter 2026 financial results, driven by strong performance in its Ambulatory and Hospital segments, with net income available to common shareholders reaching $702 million.

Tenet Healthcare announces a planned retirement transition for its Executive Vice President and Chief Information Officer, Paola Arbour, with a phased handover and continued part-time support.

Tenet Healthcare Corporation announced strong financial results for the fourth quarter and full year 2025, alongside a positive financial outlook for 2026.

Tenet Healthcare announced the completion of a strategic transaction with CommonSpirit Health for its Conifer Health Solutions subsidiary and expects 2025 Adjusted EBITDA at the upper end of its guidance.

Tenet Healthcare Corporation announced robust financial results for the second quarter of 2026, with significant increases in net operating revenues and net income, driven by strong performance in both its Hospital Operations and Ambulatory Care segments.

Tenet Healthcare Corporation reported a decrease in net income and diluted EPS for the nine months ended September 30, 2025, primarily due to significant gains on facility sales in the prior year, while its Ambulatory Care segment showed strong revenue growth.

Tenet Healthcare Corporation reports increased net operating revenues and cash flow from operations for the first half of 2025, driven by robust Ambulatory Care growth and improved hospital segment performance, despite lower net income due to prior-year asset sales.

Tenet Healthcare's Q1 2025 results show a decrease in net operating revenues primarily due to hospital divestitures, offset by growth in the Ambulatory Care segment.

Tenet Healthcare Corporation's Q3 2024 results show significant gains in net income and operating income, primarily due to strategic divestitures and growth in the ambulatory care segment.

Tenet Healthcare's second-quarter results show significant gains in net income, boosted by strategic asset sales and strong performance in its ambulatory care segment.

Tenet Healthcare's 2024 10-K filing reveals a year of strategic portfolio refinement and ambulatory care expansion, contributing to overall financial health.

Tenet Healthcare Corporation outlines its registered securities, including common stock and senior notes, along with governance and operational details in its annual 10-K filing.

Lisa Y Foo, EVP, Chief Operating Officer of Tenet Healthcare Corp, sold 10,000 shares of common stock on July 29, 2026 for $258.03 per share.

Christopher S. Lynch, a Director of Tenet Healthcare Corp, sold 3,837 shares of common stock on July 27, 2026 for $243.44 per share.

Paola M Arbour, EVP, Chief Information Officer of Tenet Healthcare Corp, sold 10,878 shares of common stock on July 27, 2026 for $243.90 per share.

James L Bierman, a Director of Tenet Healthcare Corp, sold 5,000 shares of common stock on July 27, 2026 for $244.96 per share.

Tenet Healthcare Director J. Robert Kerrey sold 5,638 shares of common stock on May 28, 2026.

Director Vineeta Agarwala was granted 1,188 restricted stock units as part of Tenet Healthcare's incentive plan.

Tenet Healthcare reports strong 2025 financial performance, including a 21.4% adjusted EBITDA margin and significant capital deployment, ahead of its 2026 Annual Meeting.

Tenet Healthcare Corporation will hold its annual shareholder meeting virtually on May 22, 2025, to vote on director elections, executive compensation, auditor ratification, and a shareholder proposal on maternal health outcomes.

Tenet Healthcare's proxy statement highlights a transformational year in 2024, marked by portfolio optimization, strong financial performance, and a focus on expanding access to specialty care.

Tenet Healthcare Corporation will hold its annual shareholders meeting virtually on May 22, 2024, to vote on director elections, executive compensation, auditor ratification, and shareholder proposals.

Tenet Healthcare's 2024 proxy statement outlines key proposals for the annual shareholder meeting, including the election of directors, executive compensation, and shareholder initiatives related to risk mitigation and ESG integration.

Vanguard Capital Management has reported beneficial ownership of 5.26% of Tenet Healthcare Corp.'s common stock as of March 31, 2026.

The Vanguard Group has filed an amendment to its Schedule 13G, reporting zero beneficial ownership in Tenet Healthcare Corp following an internal realignment.

Invesco Ltd. has filed an amended Schedule 13G, revealing its beneficial ownership of 4.4% of Tenet Healthcare Corp's common stock as of March 31, 2025.

BlackRock, Inc. has filed an Amendment No. 3 to Schedule 13G, reporting a beneficial ownership of 8.8% in Tenet Healthcare Corporation's common stock as of March 31, 2025.